-
From the Editor-in-Chief
Cancer and the MicrobiomeAltering the gut microbiota and microbiome could become a strategy for cancer prevention and treatment.
by William G. Nelson, MD, PhD
-
Forward Look
What Is CRISPR?Q&A with oncologist Howard Kaufman on the new gene-editing tool.
by Chris Palmer
-
Forward Look
Longer Treatment May Benefit Some Breast Cancer PatientsTen years of hormone therapy studied.
by Sue Rochman
-
From the Editor-in-Chief
Geriatric Oncology: Cancer Care Comes of Age?A medical subspecialty focusing on older adults with cancer is emerging as the U.S. population ages.
by William G. Nelson, MD, PhD
-
Forward Look
All About OverdiagnosisQ&A with epidemiologist Pam Marcus on why cancer screening can have risks.
by Sue Rochman
-
Forward Look
Thyroid Tumor Gets New NamePanel reclassifies a type of thyroid tumor, says it's not cancer.
by Yasmine Iqbal
-
Forward Look
Many Cancers in HIV-Positive Patients Go UntreatedStudy suggests need to educate patients with HIV and their doctors.
by Kate Yandell
-
Forward Look
Do You Know BRCA?Learn more about educational efforts to increase understanding of the 'breast cancer' gene.
by Sue Rochman
-
A Rural Challenge
Nearly 20 percent of Americans live in rural areas, but only 3 percent of oncologists practice in them. Health care providers are establishing rural outposts and using advanced technology to diagnose and treat patients living in the country.
by Charlotte Huff
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles